Clinical Trial Update: A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness [Phase 2]

View source ↗

Summary

The Phase 2 trial of Setanaxib in patients with primary biliary cholangitis has been completed, with results posted on 2025-04-24.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Setanaxib (GKT137831)

Snippet

Sponsor: Calliditas Therapeutics Suisse SA | Conditions: Primary Biliary Cholangitis, Liver Stiffness | Phase 2 | Status: COMPLETED | Results posted: 2025-04-24